Sean F. Moran Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading activity

Sean F. Moran is Chief Financial Officer of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 76,105 shares of CRBP, which is worth approximately $726,041. The most recent transaction as insider was on Jan 31, 2025, when has been sold 27,500 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.1K

56.58% 3M change

61.81% 12M change

Total Value Held $726,041

Sean F. Moran Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2025	BUY Grant, award, or other acquisition	-	27,500 Added 26.54%	76,105 Common Stock, par valu...
Jun 18 2024	SELL Open market or private sale	$82,470 $42.12 p/Share	1,958 Reduced 3.87%	48,605 Common Stock, par valu...
Jun 18 2024	BUY Exercise of conversion of derivative security	$58,740 $30.0 p/Share	1,958 Added 3.73%	50,563 Common Stock, par valu...
Jun 17 2024	SELL Open market or private sale	$314,762 $46.77 p/Share	6,730 Reduced 12.16%	48,605 Common Stock, par valu...
Jun 17 2024	BUY Exercise of conversion of derivative security	$94,893 $14.1 p/Share	6,730 Added 10.84%	55,335 Common Stock, par valu...
Jun 14 2024	SELL Open market or private sale	$466,533 $49.87 p/Share	9,355 Reduced 16.14%	48,605 Common Stock, par valu...
Jun 14 2024	BUY Exercise of conversion of derivative security	$160,251 $17.13 p/Share	9,355 Added 14.23%	56,393 Common Stock, par valu...
Apr 10 2024	BUY Exercise of conversion of derivative security	$53,610 $30.0 p/Share	1,787 Added 3.55%	48,605 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	40,176 Added 46.18%	46,818 Common Stock, par valu...
Aug 10 2022	BUY Open market or private purchase	$5,200 $0.26 p/Share	20,000 Added 9.12%	199,272 Common Stock
May 16 2022	BUY Open market or private purchase	$3,600 $0.3 p/Share	12,000 Added 6.27%	179,272 Common Stock
Mar 10 2022	BUY Open market or private purchase	$5,550 $0.37 p/Share	15,000 Added 8.23%	167,272 Common Stock
Dec 21 2020	SELL Open market or private sale	$153,125 $1.75 p/Share	87,500 Reduced 20.02%	349,610 Common Stock
Dec 21 2020	BUY Exercise of conversion of derivative security	$122,500 $1.4 p/Share	87,500 Added 16.68%	437,110 Common Stock
Dec 18 2020	SELL Open market or private sale	$75,054 $1.4 p/Share	53,610 Reduced 13.3%	349,610 Common Stock
Dec 18 2020	BUY Exercise of conversion of derivative security	$53,610 $1.0 p/Share	53,610 Added 11.74%	403,220 Common Stock
Dec 16 2020	SELL Open market or private sale	$48,738 $1.32 p/Share	36,923 Reduced 9.55%	349,610 Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	$6,277 $0.17 p/Share	36,923 Added 8.72%	386,533 Common Stock

SFM

Sean F. Moran

Chief Financial Officer

Norwood, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBP shares.

Notify only if

Value

Insider Trading

Get notified when an Corbus Pharmaceuticals Holdings, Inc. insider buys or sells CRBP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Corbus Pharmaceuticals Holdings, Inc.

Track Activities on CRBP

Account